$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv

$hofv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024042927 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$4.700M	$4.191M	$6.137M
YoY Change	-23.3%	34.32%	143.23%
Cost Of Revenue	$1.709M	$974.4K	$1.631M
YoY Change	7.64%	-33.22%	-2.41%
Gross Profit	$2.991M	$3.217M	$4.506M
YoY Change	-34.12%	93.65%	428.8%
Gross Profit Margin	63.64%	76.75%	73.43%
Selling, General & Admin	$7.199M	$6.150M	$7.539M
YoY Change	-32.68%	-50.91%	-3.49%
% of Gross Profit	240.72%	191.19%	167.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.181M	$4.159M	$4.580M
YoY Change	23.96%	62.87%	75.02%
% of Gross Profit	139.81%	129.28%	101.63%
Operating Expenses	$13.09M	$11.28M	$12.12M
YoY Change	-16.39%	-36.2%	26.99%
Operating Profit	-$8.390M	-$7.092M	-$7.617M
YoY Change	-11.94%	-51.31%	-12.39%
Interest Expense	-$7.596M	$6.522M	-$8.883M
YoY Change	114.39%	79.53%	107.37%
% of Operating Profit
Other Income/Expense, Net	-$7.099M	-$7.538M	$196.1K
YoY Change	88.5%	56.18%	-80.69%
Pretax Income	-$15.49M	-$14.63M	-$19.90M
YoY Change	16.52%	-24.56%	9.42%
Income Tax
% Of Pretax Income
Net Earnings	-$15.49M	-$14.63M	-$20.16M
YoY Change	16.52%	-24.56%	8.94%
Net Earnings / Revenue	-329.58%	-349.06%	-328.54%
Basic Earnings Per Share	-$2.41	-$2.30
Diluted Earnings Per Share	-$2.41	-$2.30	-$3.18
COMMON SHARES
Basic Shares Outstanding	6.526M shares	6.502M shares	6.435M shares
Diluted Shares Outstanding	6.528M shares	6.486M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.455M	$2.713M	$3.243M
YoY Change	-84.37%	-63.31%	-87.53%
Cash & Equivalents	$6.443M	$6.884M	$11.82M
Short-Term Investments
Other Short-Term Assets	$7.147M	$8.109M	$3.514M
YoY Change	114.08%	114.32%	5.2%
Inventory
Prepaid Expenses
Receivables	$1.131M	$1.268M	$1.108M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.733M	$12.09M	$7.866M
YoY Change	-36.33%	-12.88%	-74.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$339.2M	$341.6M	$344.4M
YoY Change	-8.55%	35.13%	38.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.411M	$2.476M
YoY Change	-86.69%	-93.19%
Other Assets	$4.988M	$4.171M	$8.573M
YoY Change	-33.87%	-42.91%	14.31%
Total Long-Term Assets	$427.2M	$427.5M	$434.0M
YoY Change	-1.98%	-4.43%	2.09%
TOTAL ASSETS
Total Short-Term Assets	$9.733M	$12.09M	$7.866M
Total Long-Term Assets	$427.2M	$427.5M	$434.0M
Total Assets	$436.9M	$439.6M	$441.9M
YoY Change	-3.14%	-4.68%	-3.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.67M	$23.36M	$21.83M
YoY Change	65.76%	38.93%	24.18%
Accrued Expenses	$3.326M	$3.321M	$3.441M
YoY Change	-2.81%	-2.83%	0.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$62.98M
YoY Change			4.82%
Total Short-Term Liabilities	$32.86M	$29.41M	$89.54M
YoY Change	-59.54%	-63.98%	9.29%
LONG-TERM LIABILITIES
Long-Term Debt	$296.9M	$287.5M	$219.5M
YoY Change	52.07%	49.79%	28.15%
Other Long-Term Liabilities	$8.970M	$9.035M	$6.084M
YoY Change	-39.52%	-41.0%	-48.4%
Total Long-Term Liabilities	$305.9M	$296.6M	$225.6M
YoY Change	45.6%	43.08%	23.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.86M	$29.41M	$89.54M
Total Long-Term Liabilities	$305.9M	$296.6M	$225.6M
Total Liabilities	$338.8M	$326.0M	$315.2M
YoY Change	16.29%	12.82%	18.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$247.3M	-$231.5M	-$216.6M
YoY Change	37.34%	39.03%	47.48%
Common Stock	$655.00	$650.00	$643.00
YoY Change	15.72%	15.04%	14.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$99.13M	$114.6M	$127.7M
YoY Change
Total Liabilities & Shareholders Equity	$436.9M	$439.6M	$441.9M
YoY Change	-3.14%	-4.68%	-3.16%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$15.49M	-$14.63M	-$20.16M
YoY Change	16.52%	-24.56%	8.94%
Depreciation, Depletion And Amortization	$4.181M	$4.159M	$4.580M
YoY Change	23.96%	62.87%	75.02%
Cash From Operating Activities	-$2.833M	-$2.500M	-$7.390M
YoY Change	-65.19%	-78.34%	1.15%
INVESTING ACTIVITIES
Capital Expenditures	$811.1K	$11.09M	$7.761M
YoY Change	-91.89%	14.62%	-55.15%
Acquisitions
YoY Change
Other Investing Activities	$1.510K	$8.127M	$4.490K
YoY Change	-99.99%	-154.18%	-100.03%
Cash From Investing Activities	-$809.6K	-$2.968M	-$7.756M
YoY Change	-107.93%	-87.97%	-77.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.202M	$512.8K	15.21M
YoY Change	3898.11%	-97.05%	-64.21%
NET CHANGE
Cash From Operating Activities	-2.833M	-$2.500M	-7.390M
Cash From Investing Activities	-809.6K	-$2.968M	-7.756M
Cash From Financing Activities	3.202M	$512.8K	15.21M
Net Change In Cash	-440.8K	-$4.955M	59.69K
YoY Change	-120.5%	-73.67%	-93.46%
FREE CASH FLOW
Cash From Operating Activities	-$2.833M	-$2.500M	-$7.390M
Capital Expenditures	$811.1K	$11.09M	$7.761M
Free Cash Flow	-$3.644M	-$13.59M	-$15.15M
YoY Change	-79.91%	-35.94%	-38.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6486044	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.30
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5629086	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.48
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	HALL OF FAME RESORT & ENTERTAINMENT COMPANY
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3235695
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2014 Champions Gateway
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Canton
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44708
CY2024Q1	dei	City Area Code CityAreaCode	(330)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	458–9176
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6525582	shares
CY2024Q1	us-gaap	Cash Cash	2713210	usd
CY2023Q4	us-gaap	Cash Cash	3243353	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	4170957	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	8572730	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2476397	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1268174	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1108460	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8109121	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3514135	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	341626103	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	344378835	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	12325227	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7274397	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7387693	usd
CY2024Q1	hofv	Project Development Costs ProjectDevelopmentCosts	69932439	usd
CY2023Q4	hofv	Project Development Costs ProjectDevelopmentCosts	59366200	usd
CY2024Q1	us-gaap	Assets Assets	439570798	usd
CY2023Q4	us-gaap	Assets Assets	441896633	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	221653857	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	219532941	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	23363469	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	21825540	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	2726806	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	1293874	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	176000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	225000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	65867451	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	62982552	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3321009	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3440630	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	8858499	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	5858682	usd
CY2024Q1	us-gaap	Liabilities Liabilities	325967091	usd
CY2023Q4	us-gaap	Liabilities Liabilities	315159219	usd
CY2024Q1	hofv	Undesignated Preferred Stock Par Or Stated Value Per Share UndesignatedPreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	hofv	Undesignated Preferred Stock Par Or Stated Value Per Share UndesignatedPreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	hofv	Undesignated Preferred Stock Shares Authorized UndesignatedPreferredStockSharesAuthorized	4917000	shares
CY2023Q4	hofv	Undesignated Preferred Stock Shares Authorized UndesignatedPreferredStockSharesAuthorized	4917000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6502437	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6502437	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6437020	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6437020	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	650	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	643	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	346097951	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	344335489	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-231531470	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-216643882	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	114567133	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	127692252	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-963426	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-954838	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	113603707	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126737414	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	439570798	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441896633	usd
CY2024Q1	us-gaap	Revenues Revenues	4191315	usd
CY2023Q1	us-gaap	Revenues Revenues	3120433	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6150364	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12528716	usd
CY2024Q1	us-gaap	Other General Expense OtherGeneralExpense	974432	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	1459203	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1145000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	4158750	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2553360	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	11283546	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	17686279	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7092231	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14565846	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	6521534	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3632637	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	955322	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	855891	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-49000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	238000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-100000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-140041	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	29952	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7537945	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4826528	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-14630176	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-19392374	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	266000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	266000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8588	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-48577	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14887588	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19609797	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.3
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.48
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6486044	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5629086	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	126737414	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	96469	usd
CY2024Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	7672	shares
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	266000	usd
CY2024Q1	hofv	Adjustments To Additional Paid In Capital Modification Of Warrants In Connection With Irg Restructuring AdjustmentsToAdditionalPaidInCapitalModificationOfWarrantsInConnectionWithIRGRestructuring	1666000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-14630176	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	113603707	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	191258112	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	651034	usd
CY2023Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	8741	shares
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	266000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-19392374	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	172250772	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-14630176	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-19392374	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4158750	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2553360	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	955322	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	855891	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	1798295	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	1681073	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1145000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	273523	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	29952	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	2905941	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1127491	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-140041	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-100000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	49000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-238000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	96469	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	651034	usd
CY2024Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	124429	usd
CY2023Q1	us-gaap	Other Noncash Expense OtherNoncashExpense	128143	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	189474	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	888740	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3106777	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1588240	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	977566	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-875060	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-76608	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-78508	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	1432932	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-110903	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3015367	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3184424	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2476875	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11542932	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	30021129	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities	15021129	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8126634	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11094441	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9679007	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2967807	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24679007	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	8722258	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	20500000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10962096	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	312431	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1537342	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	747396	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1093750	usd
CY2024Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	3500000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	150000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	512766	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17406477	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4931916	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18815462	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11816083	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33516382	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6884167	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14700920	usd
CY2024Q1	us-gaap	Cash Cash	2713210	usd
CY2023Q1	us-gaap	Cash Cash	7395025	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	4170957	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	7305895	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6884167	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14700920	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1739082	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2644324	usd
CY2024Q1	hofv	Accrued Interest Rolled Into Notes Payable In Connection With Modification AccruedInterestRolledIntoNotesPayableInConnectionWithModification	9028091	usd
CY2024Q1	hofv	Penny Warrants Received In Consideration Of Sports Betting Agreement PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement	1666000	usd
CY2024Q1	hofv	Proceeds From Sale Of Assets Held In Escrow ProceedsFromSaleOfAssetsHeldInEscrow	1500000	usd
CY2024Q1	hofv	Accrued Series B Preferred Stock Dividends AccruedSeriesBPreferredStockDividends	116000	usd
CY2023Q1	hofv	Accrued Series B Preferred Stock Dividends AccruedSeriesBPreferredStockDividends	116000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1: Organization, Nature of Business, and Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Organization and Nature of Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">Hall of Fame Resort & Entertainment Company, a Delaware corporation (together with its subsidiaries, unless the context indicates otherwise, the “Company” or “HOFRE”), was incorporated in Delaware as GPAQ Acquisition Holdings, Inc., a wholly owned subsidiary of our legal predecessor, Gordon Pointe Acquisition Corp. (“GPAQ”), a special purpose acquisition company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 1, 2020, the Company consummated a business combination with HOF Village, LLC, a Delaware limited liability company (“HOF Village”), pursuant to an Agreement and Plan of Merger dated September 16, 2019 (as amended on November 6, 2019, March 10, 2020 and May 22, 2020, the “Merger Agreement”), by and among the Company, GPAQ, GPAQ Acquiror Merger Sub, Inc., a Delaware corporation (“Acquiror Merger Sub”), GPAQ Company Merger Sub, LLC, a Delaware limited liability company (“Company Merger Sub”), HOF Village and HOF Village Newco, LLC, a Delaware limited liability company (“Newco”). The transactions contemplated by the Merger Agreement are referred to as the “Business Combination”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">The Company is a resort and entertainment company leveraging the power and popularity of professional football and its legendary players in partnership with the National Football Museum, Inc., doing business as the Pro Football Hall of Fame (“PFHOF”). Headquartered in Canton, Ohio, the Company owns the DoubleTree by Hilton located in downtown Canton and the Hall of Fame Village, which is a multi-use sports, entertainment, and media destination centered around the PFHOF’s campus. The Company is pursuing a differentiation strategy across three business verticals, including destination-based assets, HOF Village Media Group, LLC (“Hall of Fame Village Media”), and gaming.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45pt">The Company has entered into multiple agreements with PFHOF, and certain government entities, which outline the rights and obligations of each of the parties with regard to the property on which the Hall of Fame Village sits, portions of which are owned by the Company and portions of which are net leased to the Company by government and quasi-governmental entities (see Note 9 for additional information). Under these agreements, the PFHOF and the lessor entities are entitled to use portions of the Hall of Fame Village on a direct-cost basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Liquidity and Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has sustained recurring losses through March 31, 2024 and the Company’s accumulated deficit was $231.5 million as of such date. Since inception, the Company’s operations have been funded principally through the issuance of debt and equity. As of March 31, 2024, the Company had approximately $2.7 million of unrestricted cash and $4.2 million of restricted cash. During the three months ended March 31, 2024, the Company used cash for operating activities of $2.5 million. The Company has approximately $90.6 million of debt coming due through May 14, 2025. In April 2024, IRG and its affiliated lenders agreed to extend the maturity of $51.6 million of principal of its debt until March 31, 2025. On May 10, 2024, the Company amended its waterpark ground lease to provide for a cure period resulting from the Company not making a payment due in May 2024 (see Note 14 Subsequent Events).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects that it will need to raise additional financing to accomplish its development plan and fund its working capital. The Company is seeking to obtain additional funding through debt, construction lending, and equity financing. There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to meet its obligations as they come due for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Basis of Presentation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and Rule 10 of Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”). Accordingly, they do not include all of the information and notes required by U.S. GAAP. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2023, filed on March 25, 2024. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Consolidation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed consolidated financial statements include the accounts and activity of the Company and its wholly owned subsidiaries. Investments in a variable interest entity in which the Company is not the primary beneficiary, or where the Company does not own a majority interest but has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. All intercompany profits, transactions, and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company owns a 60% interest in Mountaineer GM, LLC (“Mountaineer”), whose results are consolidated into the Company’s results of operations. The portion of Mountaineer’s net income (loss) that is not attributable to the Company is included in non-controlling interest.</p>
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-231500000	usd
CY2024Q1	us-gaap	Cash Cash	2700000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	4200000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2500000	usd
CY2024Q1	us-gaap	Debt Securities DebtSecurities	90600000	usd
CY2024Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	51600000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="background-color: white"><span style="text-decoration:underline">Reclassification</span></span></p><p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="background-color: white">Certain financial statement line items of the Company’s historical presentation have been reclassified to conform to the corresponding financial statement line items. These reclassifications have no material impact on the historical operating loss, net loss, total assets, total liabilities, or stockholders’ equity previously reported.</span></p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates and assumptions for the Company relate to credit losses, depreciation, costs capitalized to project development costs, useful lives of long-lived assets, impairment, stock-based compensation, and fair value of financial instruments (including the fair value of the Company’s warrant liability). Management adjusts such estimates when facts and circumstances dictate. Actual results could differ from those estimates.</p>
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	4170957	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	8572730	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	243964	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	243081	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2024Q1	us-gaap	Payments For Film Costs PaymentsForFilmCosts	0	usd
CY2023Q1	us-gaap	Payments For Film Costs PaymentsForFilmCosts	1305000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1145000	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	176000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	225000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2000000	usd
CY2023Q4	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	225000	usd
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-49000	usd
CY2024Q1	us-gaap	Fair Value Net Asset Liability FairValueNetAssetLiability	176000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14341768	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6070274	shares
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	416792643	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	433450980	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75166540	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76746918	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	341626103	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	356704062	usd
CY2024Q1	hofv	Project Development Costs ProjectDevelopmentCosts	69932439	usd
CY2023Q4	hofv	Project Development Costs ProjectDevelopmentCosts	59366200	usd
CY2024Q1	hofv	Interest Rate Of Held For Sale InterestRateOfHeldForSale	0.80	pure
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	12325227	usd
CY2024Q1	us-gaap	Depreciation Depreciation	4158750	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2553360	usd
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	10915894	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	9163643	usd
CY2024Q1	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	349655	usd
CY2023Q1	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	6031376	usd
CY2024Q1	us-gaap	Theatrical Film Costs Development TheatricalFilmCostsDevelopment	200000	usd
CY2023Q4	us-gaap	Theatrical Film Costs Development TheatricalFilmCostsDevelopment	200000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230362032	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	8708175	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	221653857	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	229185010	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9652069	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	219532941	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	955322	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	855891	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	2905941	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1127491	usd
CY2024Q1	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2030-07-01
CY2024Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	1257424	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	804713	usd
CY2024Q1	hofv	Percentage Of Extension Fee PercentageOfExtensionFee	0.01	pure
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1830000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2000000	usd
CY2024Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.0265	pure
CY2020Q3	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	82397	shares
CY2021Q2	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	181818	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	275000	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Employee Benefit Plan StockIssuedDuringPeriodSharesEmployeeBenefitPlan	101006	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	110000	shares
CY2023Q4	us-gaap	Common Stock Discount On Shares CommonStockDiscountOnShares	39016766	usd
CY2023Q4	hofv	Underwriting Agreement Duration Period UnderwritingAgreementDurationPeriod	P90D
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	151.8
CY2024Q1	hofv	Relative Rights Of Equity Percentage RelativeRightsOfEquityPercentage	0.07	pure
CY2023Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1000
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1600000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	800	shares
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1000
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	800000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	800	shares
CY2023Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1000
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	800000	usd
CY2020Q4	hofv	Agreement Term AgreementTerm	P10Y
CY2021Q2	us-gaap	Retail Land Sales Installment Method Sales Value RetailLandSalesInstallmentMethodSalesValue	103095	usd
CY2021Q2	hofv	Number Of Notes Payable NumberOfNotesPayable	1	pure
CY2022Q3	hofv	Online Market Access Agreement Term OnlineMarketAccessAgreementTerm	P10Y
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	3500000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	3600000	usd
CY2024Q1	hofv	Activation Fund Reserves ActivationFundReserves	243661	usd
CY2023Q4	hofv	Activation Fund Reserves ActivationFundReserves	126685	usd
CY2024Q1	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	8150932	usd
CY2023Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	5441640	usd
CY2024Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	463906	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	290357	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	8858499	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	5858682	usd
CY2024Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8: Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the normal course of its business, the Company is subject to occasional legal proceedings and claims. The Company does not have any pending litigation that, separately or in the aggregate, would, in the opinion of management, have a material adverse effect on its results of operations, financial condition, or cash flows.</p>
CY2024Q1	us-gaap	Loans Payable LoansPayable	2726806	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	1293874	usd
CY2024Q1	hofv	Percentage Of Development Costs PercentageOfDevelopmentCosts	0.04	pure
CY2024Q1	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	600000	usd
CY2024Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	600000	usd
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	600000	usd
CY2024Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	600000	usd
CY2024Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	750000	usd
CY2024Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	6000000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	229820	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	304603	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	301400	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	301400	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	328600	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	39116467	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	40582290	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	37261281	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3321009	usd
CY2024Q1	us-gaap	Other Commitment OtherCommitment	9150000	usd
CY2024Q1	hofv	Annual License Fee AnnualLicenseFee	0	usd
CY2023Q1	hofv	Annual License Fee AnnualLicenseFee	300000	usd
CY2023Q1	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	28000000	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1.64	sqm
CY2024Q1	hofv	Percentage Of Bear Interest PercentageOfBearInterest	0.125	pure
CY2024Q1	us-gaap	Percentage Of Unamortized Film Costs PercentageOfUnamortizedFilmCosts	0.25	pure
CY2024Q1	hofv	Common Stock Issued To Related Party Maximum Requirement Percentage CommonStockIssuedToRelatedPartyMaximumRequirementPercentage	0.1999	pure
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7274397	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7387693	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3321009	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3440630	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	124429	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	128143	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-76608	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-78508	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P90Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P91Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	80558858	usd
CY2023Q4	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	79219467	usd
CY2024Q1	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	5945920	usd
CY2023Q4	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	5056214	usd
CY2024Q1	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	74612938	usd
CY2023Q4	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	74163253	usd
CY2024Q1	us-gaap	Lease Income LeaseIncome	641577	usd
CY2023Q1	us-gaap	Lease Income LeaseIncome	94540	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	874956	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	1174695	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1184837	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	1170697	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1002686	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	4216921	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	9624792	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Lease Term SaleLeasebackTransactionLeaseTerm	P99Y
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	307125	usd
CY2022Q3	hofv	Annual Increases AnnualIncreases	0.02	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	4375000	usd
CY2024Q1	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.1025	pure
CY2024Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	2500000	usd
CY2024Q1	hofv	Percentage Of Beneficial Membership Interest PercentageOfBeneficialMembershipInterest	0.20	pure
CY2024Q1	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	1000000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	65867451	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2324731722	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2258864271	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	60675230	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2202986526	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2142311296	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities		usd
CY2024Q1	us-gaap	Proceeds From Sale Of Held To Maturity Securities ProceedsFromSaleOfHeldToMaturitySecurities		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities		usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2024Q1	hofv	Purchase Price Of Sale On Business PurchasePriceOfSaleOnBusiness	10000000	usd
CY2024Q1	hofv	Amount Of Increments AmountOfIncrements	500000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-140041	usd
CY2024Q1	us-gaap	Business Combination Price Of Acquisition Expected BusinessCombinationPriceOfAcquisitionExpected	10000000	usd
CY2024Q1	hofv	Business Combination Workingcapitaladjustment BusinessCombinationWorkingcapitaladjustment	214222	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	9785778	usd
CY2024Q1	hofv	Business Acquisition Transaction Costs BusinessAcquisitionTransactionCosts	159144	usd
CY2024Q1	hofv	Business Combination Book Value Of Net Assets Sold BusinessCombinationBookValueOfNetAssetsSold	12213120	usd
CY2024Q1	hofv	Business Combination Investment Retained BusinessCombinationInvestmentRetained	2446445	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-140041	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2024Q1	hofv	Stock Issued During Period Value Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	hofv	Stock Issued During Period Value Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits		usd
CY2023Q1	hofv	Stock Issued During Period Vlaue Cancellation Of Fractional StockIssuedDuringPeriodVlaueCancellationOfFractional		usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	hofv	Accrued Interest Rolled Into Notes Payable In Connection With Modification AccruedInterestRolledIntoNotesPayableInConnectionWithModification		usd
CY2023Q1	hofv	Penny Warrants Received In Consideration Of Sports Betting Agreement PennyWarrantsReceivedInConsiderationOfSportsBettingAgreement		usd
CY2023Q1	hofv	Proceeds From Sale Of Assets Held In Escrow ProceedsFromSaleOfAssetsHeldInEscrow		usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001708176

Files In Submission

Name	View Source	Status
0001213900-24-042927-index-headers.html	Edgar Link	pending
0001213900-24-042927-index.html	Edgar Link	pending
0001213900-24-042927.txt	Edgar Link	pending
0001213900-24-042927-xbrl.zip	Edgar Link	pending
ea0205406-10q_hall.htm	Edgar Link	pending
ea020540601ex10-15_hall.htm	Edgar Link	pending
ea020540601ex31-1_hall.htm	Edgar Link	pending
ea020540601ex31-2_hall.htm	Edgar Link	pending
ea020540601ex32_hall.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hofv-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hofv-20240331_cal.xml	Edgar Link	unprocessable
hofv-20240331_def.xml	Edgar Link	unprocessable
hofv-20240331_lab.xml	Edgar Link	unprocessable
hofv-20240331_pre.xml	Edgar Link	unprocessable
ea0205406-10q_hall_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv

2024 Q2 Form 10-Q Financial Statement

#000121390024042927 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOFV Hall of Fame Resort & Entertainment Co Stock $hofv

2024 Q2 Form 10-Q Financial Statement

#000121390024042927 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HOFV
Hall of Fame Resort & Entertainment Co Stock $hofv